Bayer Rivaroxaban tablets win CDSCO Committee nod for waiver of local clinical trial; directed to carry Phase IV trial Medical Dialogues Bureau8 Aug 2019 11:58 AMNew Delhi: The apex drug regulatory body, Central Drugs Standard Control Organisation's (CDSCO) Technical Committee has recommended for grant of...
Cancer Drug Patent Issues: Delhi HC junks Bayer plea to block Natco Pharma Regonat Farhat Nasim15 July 2019 9:22 AMNew Delhi: The Delhi High Court recently junked the injunction petition filed by the German Drugmaker to restrain the Hyderabad-based Natco Pharma...
GSK offers concessions to address Pfizer deal concerns Farhat Nasim23 Jun 2019 3:29 AMGSK announced the deal in December last year, a move which will put it ahead of rivals Johnson & Johnson, Bayer and Sanofi.BRUSSELS:...
GSK forms drug discovery alliance with University of California CRISPR researchers Medical Dialogues Bureau14 Jun 2019 6:54 AMBritish drugmaker GSK said it has struck a research deal with the early pioneers of a prominent gene-editing technology at the University of...
Pfizer, GSK consumer healthcare venture to focus on China, US market Farhat Nasim7 April 2019 3:44 AMLONDON: The United States and China will be key focuses for the consumer healthcare venture being formed by GlaxoSmithKline and Pfizer, as the...
JnJ, Bayer settles Xarelto lawsuits for 775 million Dollar Farhat Nasim27 March 2019 6:54 AMLawsuits over Xarelto began piling up in 2014 and the companies had so far won all six trials over Xarelto's alleged bleeding risk.U.S: Bayer AG and...
Bayer asks judge to limit evidence in another round up cancer trial Medical Dialogues Bureau24 Jan 2019 3:45 AMBayer denies allegations that glyphosate causes cancer, saying decades of independent studies have shown the world's most widely-used weed killer to...
Bayer reduces combined sales estimate for its experimental drugs Medical Dialogues Bureau8 Dec 2018 3:50 AMFRANKFURT: Germany's Bayer, which acquired seed company, Monsanto, this year, reduced its combined sales estimate for its most promising experimental...
Bayer to slash 12,000 jobs after Monsanto takeover Medical Dialogues Bureau30 Nov 2018 3:30 AMBERLIN: German chemical and pharmaceutical giant Bayer said Thursday it would slash 12,000 jobs in a major restructuring following the mammoth...
Loxo,Bayer gets U.S approval for cancer drug Larotrectinib Medical Dialogues Bureau28 Nov 2018 3:36 AMNew Delhi: A Loxo Oncology Inc drug larotrectinib shown to be effective against a wide variety of cancers driven by a single, rare genetic mutation...
Bayer, Johnson and Johnson's heart drug Xarelto fails trial to widen use Ruby Khatun Khatun28 Aug 2018 4:15 AMFRANKFURT: Bayer and Johnson and Johnson's campaign to widen the market for its heart drug Xarelto hit a snag on Sunday when a study for a potential...
Loxo-Bayer cancer drug gets priority review from FDA Ruby Khatun Khatun1 Jun 2018 4:00 AMLoxo Oncology and Bayer AG said the U.S. Food and Drug Administration granted priority review to their cancer drug and would decide on the marketing...
